Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol to study direct (de)phosphorylation events on a proteome-wide scale using on-bead in vitro enzyme assays.

STAR protocols·2026
Same author

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization.

Molecular oncology·2026
Same author

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

International journal of cancer·2026
Same author

Lymphoid tissue chemokines limit priming duration to preserve CD8<sup>+</sup> T cell functionality.

Science (New York, N.Y.)·2026
Same author

Multiomics analysis reveals dermokine as a regulator of keratinocyte differentiation and adhesion.

JCI insight·2026
Same author

Exploration of the proxiOME of large subunit ribosomal proteins reveals Acl1 and Bcl1 as cooperating dedicated chaperones of Rpl1.

Nucleic acids research·2026

Related Experiment Video

Updated: Mar 15, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K

Quantitative Proteomics Analysis of Leukemia Cells.

Sebastian Halbach1,2,3, Jörn Dengjel4,5,6,7, Tilman Brummer8,9,10,11

  • 1Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Stefan Meier Strasse 17, 79104, Freiburg im Breisgau, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|September 2, 2016
PubMed
Summary

Researchers analyzed the Bcr-Abl signaling network in chronic myeloid leukemia (CML) cells using quantitative proteomics. This study details immunoprecipitation and SILAC methods to identify key proteins involved in CML pathogenesis.

Keywords:
Bcr-AblChronic myeloid leukemiaGab2ImmunoprecipitationMass spectrometryPosttranslational modificationProtein complexProtein dynamicsProteomicsSILAC

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

11.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

11.1K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Chronic myeloid leukemia (CML) is characterized by the Bcr-Abl fusion kinase.
  • The Bcr-Abl kinase controls a complex signaling network crucial for CML development.
  • Understanding this network is vital for targeted therapeutic strategies.

Purpose of the Study:

  • To detail methods for analyzing the Bcr-Abl signaling network.
  • To apply quantitative proteomics for identifying pathway components.
  • To investigate protein interactions within the Bcr-Abl pathway in a CML model.

Main Methods:

  • Utilized immunoprecipitation techniques to isolate Bcr-Abl associated proteins.
  • Employed stable isotope labeling by amino acids in cell culture (SILAC) for quantitative proteomic analysis.
  • Applied mass spectrometry (MS) for high-throughput protein identification and quantification.

Main Results:

  • Successfully identified multiple components of the Bcr-Abl signaling network in K562 cells.
  • Quantified relative protein abundance changes within the pathway.
  • Established a detailed map of protein interactions.

Conclusions:

  • Quantitative proteomics, particularly SILAC, is effective for dissecting complex signaling networks like Bcr-Abl.
  • This methodology provides a foundation for further investigation into CML mechanisms.
  • The identified proteins and interactions offer potential targets for novel CML therapies.